Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL2058190 | 1.00 | ALDH1A1 (0.46) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| Glycerin SCHEMBL28301031 | 1.00 | ALDH1A1 (0.46) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| Glycerin SCHEMBL11517976 | 0.95 | ALDH1A1 (0.43) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| SCHEMBL2057584 | 0.90 | THRB (0.43) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| Propylene Glycol SCHEMBL27869488 | 0.89 | ALDH1A1 (0.46) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| Propylene Glycol SCHEMBL5347252 | 0.89 | ALDH1A1 (0.46) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| E968 SCHEMBL2057570 | 0.89 | ALDH1A1 (0.47) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| SCHEMBL28534672 | 0.88 | ALDH1A1 (0.41) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| SCHEMBL20746511 | 0.87 | CYP2C19 (0.53) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E | |
| SCHEMBL20746509 | 0.87 | CYP2C19 (0.53) | ALDH1A1LMNATDP1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117069949-A | Glycidyl azide polyether-tetrahydrofuran energetic copolyether with alternating multiblock structure and synthesis method thereof | 南京理工大学 | 2023-11-17 | — | — | CN | disclosed |
| CN-116889562-A | Macrophage/microglial cell in neuroinflammation related to neurodegenerative diseases | 通用医疗公司 | 2023-10-17 | — | — | CN | disclosed |
| CN-109922800-B | Macrophage/microglial cell in neuroinflammation related to neurodegenerative diseases | 通用医疗公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-113727736-A | Cromoglycate and its use | 通用医疗公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-113164472-A | Itraconazole analogue and application thereof | 约翰霍普金斯大学 | 2021-07-23 | — | — | CN | disclosed |
| CN-112334509-A | Transesterification process for the simultaneous production of at least two different types of polycarbonate in a production plant | 科思创知识产权两合公司 | 2021-02-05 | — | — | CN | disclosed |
| CN-106146480-B | A kind of preparation method of Itraconazole | 山东罗欣药业集团恒欣药业有限公司 | 2019-08-06 | — | — | CN | disclosed |
| CN-106146480-A | A kind of preparation method of itraconazole | 山东罗欣药业集团恒欣药业有限公司 | 2016-11-23 | — | — | CN | disclosed |
| EP-2147074-A1 | ADHESIVE PRECURSOR | The Procter and Gamble Company (US) | 2010-01-27 | — | — | EP | disclosed |
| WO-2008139410-A1 | ADHESIVE PRECURSOR | THE PROCTER & GAMBLE COMPANY (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080281285-A1 | Process for Bonding a Material to a Substrate with an Adhesive Precursor Forming an Adhesive as a Product of Ester Condensation and Products Bonded with Such Adhesive Precursor | PROCTER & GAMBLE COMPANY, THE | 2008-11-13 | — | — | US | disclosed |
| US-6346518-B1 | ADMINISTERING AS A COMPLEX WITH CYCLODEXTRIN TO TREAT FUNGAL INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-02-12 | — | — | US | disclosed |
| EP-0631578-B1 | ITRACONAZOLE AND SAPERCONAZOLE STEREOISOMERS | JANSSEN PHARMACEUTICA NV (BE) | 2001-05-23 | — | — | EP | disclosed |
| US-5998413-A | FUNGICIDE | JANSSEN PHARMACEUTICA, N.V. (BE) | 1999-12-07 | — | — | US | disclosed |
| EP-0349066-B1 | Preparation of enantiomers of dropropizine | DSM NV (NL) | 1995-04-26 | — | — | EP | disclosed |
| EP-0631578-A1 | ITRACONAZOLE AND SAPERCONAZOLE STEREOISOMERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1995-01-04 | — | — | EP | disclosed |
| WO-1993019061-A1 | ITRACONAZOLE AND SAPERCONAZOLE STEREOISOMERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-09-30 | — | — | WO | disclosed |
| EP-0147847-A2 | Optically active compounds with antitussive and central sedative activity, a process for the preparation thereof and compositions containing the same | DOMPE' FARMACEUTICI S.p.A. (IT) | 1985-07-10 | — | — | EP | disclosed |
| US-4237250-A | Polyurethanes containing aryl sulfonic acid alkyl ester groups | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-02 | — | — | US | disclosed |